Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

Go back to Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
(NASDAQ: ACHV) Delayed: 7.84 --0 (-0%)
Previous Close $7.84    52 Week High
Open $7.84    52 Week Low
Day High $7.84    P/E N/A 
Day Low $7.84    EPS
Volume